Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[Eculizumab][1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
2ABP 959 - biosimilar to eculizumab[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
3ABP 959 - proposed biosimilar to eculizumab[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
4ECULIZUMAB[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 11, 13, 14, 61, 62, 109, 221, 223 💬
5Eculizumab (Soliris®)[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 13 💬
6Eculizumab administration[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 13 💬
7Eculizumab Injection[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
8Eculizumab+IVMP[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 13 💬
9Other: Eculizumab[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 109 💬
10SB12 (proposed eculizumab biosimilar)[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
11Soliris (eculizumab)[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
12Soliris ™ (eculizumab)[1] Eculizumab (Eculizumab)[1] Eculizumab (Eculizumab, Eculizumab-aagh, Eculizumab-aeeb) 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬